On Wednesday, Sabra Healthcare REIT earned a positive adjustment to its Relative Strength (RS) Rating, from 65 to 71.
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks compares to other publicly traded companies.
History reveals that the best stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if Sabra Healthcare REIT can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
While it's not currently an ideal time to buy shares, see if the stock is able to offer and clear a proper buy point.
Taking a look at revenue and profit performance, Sabra Healthcare REIT has posted three quarters of accelerating earnings growth. Sales gains have also moved higher over the same time frame.
The company holds the No. 16 rank among its peers in the Finance-Property REITs industry group. Strawberry Fields REIT, Equinix and Essential Prop Realty Tr are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
